The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: A before-after cluster phase II trial

Carla Ida Ripamonti, Cesarina Prandi, Massimo Costantini, Elisa Perfetti, Fabio Pellegrini, Marco Visentin, Lorenza Garrino, Anna De Luca, Maria Adelaide Pessi, Carlo Peruselli

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Cancer-related pain continues to be a major healthcare issue worldwide. Despite the availability of effective analgesic drugs, published guidelines and educational programs for Health Care Professionals (HCPs) the symptom is still under-diagnosed and its treatment is not appropriate in many patients. The objective of the study is to evaluate the efficacy of the Pac-IFicO programme in improving the quality of pain management in hospitalised cancer patients. Methods/design. This is a before-after cluster phase II study. After the before assessment, the experimental intervention - the Pac-IFicO programme - will be implemented in ten medicine, oncology and respiratory disease hospital wards. The same assessment will be repeated after the completion of the intervention. The Pac-IFicO programme is a complex intervention with multiple components. It includes focus group with ward professionals for identifying possible local obstacles to optimal pain control, informative material for the patients, an educational program performed through guides from the wards, and an organisational intervention to the ward. The primary end-point of the study is the proportion of cancer patients with severe pain. Secondary end-points include opioids administered in the wards, knowledge in pain management, and quality of pain management. We plan to recruit about 500 cancer patients. This sample size should be sufficient, after appropriate statistical adjustments for clustering, to detect an absolute decrease in the primary end-point from 20% to 9%. Discussion. This trial is aimed at exploring with an experimental approach the efficacy of a new quality improvement educational intervention. Trial registration. ClinicalTrials.gov: NCT02035098.

Original languageEnglish
Article number15
JournalBMC Palliative Care
Volume13
Issue number1
DOIs
Publication statusPublished - Mar 29 2014

Fingerprint

Program Evaluation
Pain Management
Neoplasms
Delivery of Health Care
Pain
Pulmonary Medicine
Quality Improvement
Focus Groups
Sample Size
Opioid Analgesics
Cluster Analysis
Analgesics
Guidelines

Keywords

  • Cancer
  • Educational program
  • Information of the patients
  • Pac-IFicO program
  • Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients : A before-after cluster phase II trial. / Ripamonti, Carla Ida; Prandi, Cesarina; Costantini, Massimo; Perfetti, Elisa; Pellegrini, Fabio; Visentin, Marco; Garrino, Lorenza; De Luca, Anna; Pessi, Maria Adelaide; Peruselli, Carlo.

In: BMC Palliative Care, Vol. 13, No. 1, 15, 29.03.2014.

Research output: Contribution to journalArticle

Ripamonti, Carla Ida ; Prandi, Cesarina ; Costantini, Massimo ; Perfetti, Elisa ; Pellegrini, Fabio ; Visentin, Marco ; Garrino, Lorenza ; De Luca, Anna ; Pessi, Maria Adelaide ; Peruselli, Carlo. / The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients : A before-after cluster phase II trial. In: BMC Palliative Care. 2014 ; Vol. 13, No. 1.
@article{d4cec4228a3a4f469eadf63a7120251e,
title = "The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: A before-after cluster phase II trial",
abstract = "Background: Cancer-related pain continues to be a major healthcare issue worldwide. Despite the availability of effective analgesic drugs, published guidelines and educational programs for Health Care Professionals (HCPs) the symptom is still under-diagnosed and its treatment is not appropriate in many patients. The objective of the study is to evaluate the efficacy of the Pac-IFicO programme in improving the quality of pain management in hospitalised cancer patients. Methods/design. This is a before-after cluster phase II study. After the before assessment, the experimental intervention - the Pac-IFicO programme - will be implemented in ten medicine, oncology and respiratory disease hospital wards. The same assessment will be repeated after the completion of the intervention. The Pac-IFicO programme is a complex intervention with multiple components. It includes focus group with ward professionals for identifying possible local obstacles to optimal pain control, informative material for the patients, an educational program performed through guides from the wards, and an organisational intervention to the ward. The primary end-point of the study is the proportion of cancer patients with severe pain. Secondary end-points include opioids administered in the wards, knowledge in pain management, and quality of pain management. We plan to recruit about 500 cancer patients. This sample size should be sufficient, after appropriate statistical adjustments for clustering, to detect an absolute decrease in the primary end-point from 20{\%} to 9{\%}. Discussion. This trial is aimed at exploring with an experimental approach the efficacy of a new quality improvement educational intervention. Trial registration. ClinicalTrials.gov: NCT02035098.",
keywords = "Cancer, Educational program, Information of the patients, Pac-IFicO program, Pain",
author = "Ripamonti, {Carla Ida} and Cesarina Prandi and Massimo Costantini and Elisa Perfetti and Fabio Pellegrini and Marco Visentin and Lorenza Garrino and {De Luca}, Anna and Pessi, {Maria Adelaide} and Carlo Peruselli",
year = "2014",
month = "3",
day = "29",
doi = "10.1186/1472-684X-13-15",
language = "English",
volume = "13",
journal = "BMC Palliative Care",
issn = "1472-684X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients

T2 - A before-after cluster phase II trial

AU - Ripamonti, Carla Ida

AU - Prandi, Cesarina

AU - Costantini, Massimo

AU - Perfetti, Elisa

AU - Pellegrini, Fabio

AU - Visentin, Marco

AU - Garrino, Lorenza

AU - De Luca, Anna

AU - Pessi, Maria Adelaide

AU - Peruselli, Carlo

PY - 2014/3/29

Y1 - 2014/3/29

N2 - Background: Cancer-related pain continues to be a major healthcare issue worldwide. Despite the availability of effective analgesic drugs, published guidelines and educational programs for Health Care Professionals (HCPs) the symptom is still under-diagnosed and its treatment is not appropriate in many patients. The objective of the study is to evaluate the efficacy of the Pac-IFicO programme in improving the quality of pain management in hospitalised cancer patients. Methods/design. This is a before-after cluster phase II study. After the before assessment, the experimental intervention - the Pac-IFicO programme - will be implemented in ten medicine, oncology and respiratory disease hospital wards. The same assessment will be repeated after the completion of the intervention. The Pac-IFicO programme is a complex intervention with multiple components. It includes focus group with ward professionals for identifying possible local obstacles to optimal pain control, informative material for the patients, an educational program performed through guides from the wards, and an organisational intervention to the ward. The primary end-point of the study is the proportion of cancer patients with severe pain. Secondary end-points include opioids administered in the wards, knowledge in pain management, and quality of pain management. We plan to recruit about 500 cancer patients. This sample size should be sufficient, after appropriate statistical adjustments for clustering, to detect an absolute decrease in the primary end-point from 20% to 9%. Discussion. This trial is aimed at exploring with an experimental approach the efficacy of a new quality improvement educational intervention. Trial registration. ClinicalTrials.gov: NCT02035098.

AB - Background: Cancer-related pain continues to be a major healthcare issue worldwide. Despite the availability of effective analgesic drugs, published guidelines and educational programs for Health Care Professionals (HCPs) the symptom is still under-diagnosed and its treatment is not appropriate in many patients. The objective of the study is to evaluate the efficacy of the Pac-IFicO programme in improving the quality of pain management in hospitalised cancer patients. Methods/design. This is a before-after cluster phase II study. After the before assessment, the experimental intervention - the Pac-IFicO programme - will be implemented in ten medicine, oncology and respiratory disease hospital wards. The same assessment will be repeated after the completion of the intervention. The Pac-IFicO programme is a complex intervention with multiple components. It includes focus group with ward professionals for identifying possible local obstacles to optimal pain control, informative material for the patients, an educational program performed through guides from the wards, and an organisational intervention to the ward. The primary end-point of the study is the proportion of cancer patients with severe pain. Secondary end-points include opioids administered in the wards, knowledge in pain management, and quality of pain management. We plan to recruit about 500 cancer patients. This sample size should be sufficient, after appropriate statistical adjustments for clustering, to detect an absolute decrease in the primary end-point from 20% to 9%. Discussion. This trial is aimed at exploring with an experimental approach the efficacy of a new quality improvement educational intervention. Trial registration. ClinicalTrials.gov: NCT02035098.

KW - Cancer

KW - Educational program

KW - Information of the patients

KW - Pac-IFicO program

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=84897985877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897985877&partnerID=8YFLogxK

U2 - 10.1186/1472-684X-13-15

DO - 10.1186/1472-684X-13-15

M3 - Article

AN - SCOPUS:84897985877

VL - 13

JO - BMC Palliative Care

JF - BMC Palliative Care

SN - 1472-684X

IS - 1

M1 - 15

ER -